Procter & Gamble Hygiene and Health Care Limited (BOM: 500459)
India
· Delayed Price · Currency is INR | Market Cap | 490.66B |
| Revenue (ttm) | 42.03B |
| Net Income (ttm) | 6.76B |
| Shares Out | 32.46M |
| EPS (ttm) | 208.32 |
| PE Ratio | 72.56 |
| Forward PE | n/a |
| Dividend | 195.00 (1.29%) |
| Ex-Dividend Date | Nov 19, 2024 |
| Volume | 9 |
| Open | 15,387 |
| Previous Close | 15,447 |
| Day's Range | 15,286 - 15,416 |
| 52-Week Range | 15,286 - 17,748 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 31, 2025 |
About Procter & Gamble Hygiene and Health Care
Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies,... [Read more]
Financial Performance
In 2024, Procter & Gamble Hygiene and Health Care's revenue was 42.06 billion, an increase of 7.35% compared to the previous year's 39.18 billion. Earnings were 6.75 billion, a decrease of -0.46%.
Financial StatementsNews
P&G Q2 Results: Revenue at Rs 1,132.73 crore, down 0.2% YoY; Net profit at Rs 211.9 crore, up 0.6% YoY
Procter & Gamble Hygiene and Health Care Limited has released its Q2 FY25 financial results, with a slight year-over-year decline in revenue and a stable growth in net profit. The company reported rev...